LeMaitre Vascular, Inc. (LMAT)
USD 90.34
(-0.65%)
USD 90.34
(-0.65%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 90.33 Million USD | 11.89% |
| 2022 | 74.96 Million USD | 15.4% |
| 2021 | 64.95 Million USD | 15.38% |
| 2020 | 56.3 Million USD | -4.04% |
| 2019 | 58.67 Million USD | 10.27% |
| 2018 | 53.2 Million USD | 7.28% |
| 2017 | 49.59 Million USD | 6.42% |
| 2016 | 46.6 Million USD | 8.34% |
| 2015 | 43.01 Million USD | 4.06% |
| 2014 | 41.33 Million USD | 1.82% |
| 2013 | 40.59 Million USD | 10.09% |
| 2012 | 36.87 Million USD | 5.28% |
| 2011 | 35.02 Million USD | -1.06% |
| 2010 | 35.4 Million USD | 5.77% |
| 2009 | 33.47 Million USD | -4.61% |
| 2008 | 35.08 Million USD | 4.51% |
| 2007 | 33.57 Million USD | 30.73% |
| 2006 | 25.68 Million USD | 26.02% |
| 2005 | 20.38 Million USD | 21.23% |
| 2004 | 16.81 Million USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 10.45 Million USD | 30.65% |
| 2001 | 7.99 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 24.03 Million USD | 6.25% |
| 2024 Q2 | 22.61 Million USD | -8.77% |
| 2024 Q1 | 24.79 Million USD | 14.65% |
| 2023 FY | 83.87 Million USD | 11.89% |
| 2023 Q1 | 22.7 Million USD | 18.95% |
| 2023 Q2 | 22.45 Million USD | -1.1% |
| 2023 Q3 | 21.63 Million USD | -3.65% |
| 2023 Q4 | 21.62 Million USD | -0.06% |
| 2022 FY | 74.96 Million USD | 15.4% |
| 2022 Q2 | 18.91 Million USD | 4.91% |
| 2022 Q1 | 18.03 Million USD | 2.15% |
| 2022 Q4 | 19.08 Million USD | 0.88% |
| 2022 Q3 | 18.92 Million USD | 0.01% |
| 2021 Q2 | 15.65 Million USD | -1.26% |
| 2021 Q3 | 15.79 Million USD | 0.88% |
| 2021 FY | 64.95 Million USD | 15.38% |
| 2021 Q4 | 17.65 Million USD | 11.79% |
| 2021 Q1 | 15.85 Million USD | 6.71% |
| 2020 Q3 | 13.15 Million USD | 8.22% |
| 2020 FY | 56.3 Million USD | -4.04% |
| 2020 Q4 | 14.85 Million USD | 12.93% |
| 2020 Q1 | 16.13 Million USD | 7.68% |
| 2020 Q2 | 12.15 Million USD | -24.63% |
| 2019 Q1 | 15.02 Million USD | 10.32% |
| 2019 Q3 | 14.26 Million USD | -0.97% |
| 2019 Q4 | 14.98 Million USD | 5.04% |
| 2019 FY | 58.67 Million USD | 10.27% |
| 2019 Q2 | 14.4 Million USD | -4.19% |
| 2018 Q3 | 12.64 Million USD | -5.14% |
| 2018 Q1 | 13.61 Million USD | 14.1% |
| 2018 FY | 53.2 Million USD | 7.28% |
| 2018 Q4 | 13.62 Million USD | 7.76% |
| 2018 Q2 | 13.32 Million USD | -2.09% |
| 2017 FY | 49.59 Million USD | 6.42% |
| 2017 Q4 | 11.93 Million USD | -4.74% |
| 2017 Q3 | 12.52 Million USD | 4.54% |
| 2017 Q2 | 11.98 Million USD | -8.97% |
| 2017 Q1 | 13.16 Million USD | 7.12% |
| 2016 FY | 46.6 Million USD | 8.34% |
| 2016 Q3 | 11.67 Million USD | 0.79% |
| 2016 Q2 | 11.58 Million USD | 4.78% |
| 2016 Q4 | 12.28 Million USD | 5.22% |
| 2016 Q1 | 11.05 Million USD | -2.28% |
| 2015 Q4 | 11.31 Million USD | 7.19% |
| 2015 FY | 43.01 Million USD | 4.06% |
| 2015 Q3 | 10.55 Million USD | 2.12% |
| 2015 Q2 | 10.33 Million USD | -4.37% |
| 2015 Q1 | 10.8 Million USD | 8.13% |
| 2014 Q3 | 10.14 Million USD | -0.03% |
| 2014 Q4 | 9.99 Million USD | -1.46% |
| 2014 FY | 41.33 Million USD | 1.82% |
| 2014 Q1 | 11.05 Million USD | 2.49% |
| 2014 Q2 | 10.14 Million USD | -8.2% |
| 2013 Q3 | 9.94 Million USD | 1.53% |
| 2013 Q4 | 10.78 Million USD | 8.49% |
| 2013 Q1 | 10.08 Million USD | 3.33% |
| 2013 FY | 40.59 Million USD | 10.09% |
| 2013 Q2 | 9.79 Million USD | -2.91% |
| 2012 Q3 | 9.01 Million USD | -0.84% |
| 2012 Q4 | 9.75 Million USD | 8.25% |
| 2012 Q2 | 9.09 Million USD | 0.82% |
| 2012 Q1 | 9.01 Million USD | 5.09% |
| 2012 FY | 36.87 Million USD | 5.28% |
| 2011 FY | 35.02 Million USD | -1.06% |
| 2011 Q1 | 9.09 Million USD | -3.36% |
| 2011 Q2 | 8.82 Million USD | -2.97% |
| 2011 Q3 | 8.53 Million USD | -3.29% |
| 2011 Q4 | 8.57 Million USD | 0.54% |
| 2010 Q3 | 8.36 Million USD | -2.49% |
| 2010 Q4 | 9.4 Million USD | 12.47% |
| 2010 FY | 35.4 Million USD | 5.77% |
| 2010 Q1 | 9.04 Million USD | 1.16% |
| 2010 Q2 | 8.58 Million USD | -5.17% |
| 2009 Q2 | 8.09 Million USD | 1.43% |
| 2009 Q1 | 7.98 Million USD | 6.87% |
| 2009 FY | 33.47 Million USD | -4.61% |
| 2009 Q4 | 8.94 Million USD | 5.85% |
| 2009 Q3 | 8.45 Million USD | 4.37% |
| 2008 FY | 35.08 Million USD | 4.51% |
| 2008 Q2 | 9.4 Million USD | -9.9% |
| 2008 Q3 | 7.77 Million USD | -17.41% |
| 2008 Q4 | 7.46 Million USD | -3.87% |
| 2008 Q1 | 10.44 Million USD | 14.7% |
| 2007 FY | 33.57 Million USD | 30.73% |
| 2007 Q4 | 9.1 Million USD | 12.84% |
| 2007 Q2 | 8.06 Million USD | -3.36% |
| 2007 Q3 | 8.06 Million USD | 0.09% |
| 2007 Q1 | 8.34 Million USD | 19.12% |
| 2006 Q1 | 5.81 Million USD | 119.85% |
| 2006 Q4 | 7 Million USD | 18.76% |
| 2006 FY | 25.68 Million USD | 26.02% |
| 2006 Q3 | 5.89 Million USD | -15.38% |
| 2006 Q2 | 6.96 Million USD | 19.79% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | -29.3 Million USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | 20.38 Million USD | 21.23% |
| 2005 Q1 | - USD | 100.0% |
| 2004 FY | 16.81 Million USD | 0.0% |
| 2004 Q4 | -24.59 Million USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2002 FY | 10.45 Million USD | 30.65% |
| 2001 FY | 7.99 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 13.362% |
| AngioDynamics, Inc. | 252.41 Million USD | 64.211% |
| AtriCure, Inc. | 327.05 Million USD | 72.378% |
| Avinger, Inc. | 18.63 Million USD | -384.693% |
| Azenta, Inc. | 336.26 Million USD | 73.135% |
| BioLife Solutions, Inc. | 117.57 Million USD | 23.168% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 95.049% |
| Daxor Corporation | 1.28 Million USD | -6954.74% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | -273.432% |
| Femasys Inc. | 15.2 Million USD | -494.31% |
| GlucoTrack, Inc. | 7.1 Million USD | -1171.636% |
| Harvard Bioscience, Inc. | 58.58 Million USD | -54.209% |
| Hologic, Inc. | 1.34 Billion USD | 93.284% |
| ICU Medical, Inc. | 717.04 Million USD | 87.402% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 96.951% |
| KORU Medical Systems, Inc. | 26.1 Million USD | -246.014% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 75804.146% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 75804.146% |
| Masimo Corporation | 867 Million USD | 89.581% |
| Microbot Medical Inc. | 9.85 Million USD | -816.662% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -390.427% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 80.358% |
| Nephros, Inc. | 9.78 Million USD | -823.314% |
| NovoCure Limited | 613.92 Million USD | 85.285% |
| NEXGEL, Inc. | 4.09 Million USD | -2105.493% |
| NEXGEL, Inc. | 4.09 Million USD | -2105.493% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 11.645% |
| OraSure Technologies, Inc. | 125.34 Million USD | 27.928% |
| Pro-Dex, Inc. | 7.37 Million USD | -1124.41% |
| Pulse Biosciences, Inc. | 43.57 Million USD | -107.319% |
| Predictive Oncology Inc. | 15.22 Million USD | -493.17% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -960.031% |
| QuidelOrtho Corporation | 1.35 Billion USD | 93.335% |
| Repligen Corporation | 261.12 Million USD | 65.404% |
| Sanara MedTech Inc. | 61.12 Million USD | -47.785% |
| STAAR Surgical Company | 224.55 Million USD | 59.77% |
| Sharps Technology, Inc. | 10.12 Million USD | -792.072% |
| Utah Medical Products, Inc. | 13.26 Million USD | -581.223% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 94.964% |
| Jin Medical International Ltd. | 3.91 Million USD | -2205.944% |